Societal cost-effectiveness analysis of the 21-gene assay in estrogen-receptor–positive, lymph-node–negative early-stage breast cancer in Japan

Overview of attention for article published in BMC Health Services Research, September 2014

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 306 followers.

21-gene assay increases #QALYs by 0.24/woman at cost/QALY gained of $6368 in ER+ early #breastcancer in Japan http://t.co/OKEo3ZUIBT

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.